Internal Medicine V - Pulmonary Division, University Hospital Homburg, Homburg, Germany.
Crit Care Med. 2010 Mar;38(3):871-8. doi: 10.1097/CCM.0b013e3181cdf725.
To test the hypothesis that the lectin-like domain of tumor necrosis factor, mimicked by the TIP peptide, can improve lung function after unilateral orthotopic lung isotransplantation. Because of a lack of a specific treatment for ischemia reperfusion-mediated lung injury, accompanied by a disrupted barrier integrity and a dysfunctional alveolar liquid clearance, alternative therapies restoring these parameters after lung transplantation are required.
Prospective, randomized laboratory investigation.
University-affiliated laboratory.
Adult female rats.
Tuberoinfundibular peptide, mimicking the lectin-like domain of tumor necrosis factor, mutant TIP peptide, N,N'-diacetylchitobiose/TIP peptide, and amiloride/TIP peptide were instilled intratracheally in the left lung immediately before the isotransplantation was performed. An additional group received an intravenous TIP peptide treatment, 1.5 mins before transplantation. Studies using isolated rat type II alveolar epithelial cell monolayers and ovine pulmonary endothelial cells were also performed.
Intratracheal pretreatment of the transplantable left lung with the TIP peptide, but not with an inactive mutant TIP peptide, resulted in significantly improved oxygenation 24 hrs after transplantation. This treatment led to a significantly reduced neutrophil content in the lavage fluid. Both the effects on oxygenation and neutrophil infiltration were inhibited by the epithelial sodium channel blocker amiloride. The TIP peptide blunted reactive oxygen species production in pulmonary artery endothelial cells under hypoxia and reoxygenation and reduced reactive oxygen species content in the transplanted rat lungs in vivo. Ussing chamber experiments using monolayers of primary type II rat pneumocytes indicated that the primary site of action of the peptide was on the apical side of these cells.
These data demonstrate that the TIP peptide significantly improves lung function after lung transplantation in the rat, in part, by reducing neutrophil content and reactive oxygen species generation. These studies suggest that the TIP peptide is a potential therapeutic agent against the ischemia reperfusion injury associated with lung transplantation.
通过模拟肿瘤坏死因子凝集素样结构域的 TIP 肽,检验以下假设,即在单侧原位肺同种异体移植后,该肽可以改善肺功能。由于缺乏针对缺血再灌注介导的肺损伤的特异性治疗方法,这种损伤会导致屏障完整性受损和肺泡液体清除功能障碍,因此,肺移植后需要采用替代疗法来恢复这些参数。
前瞻性、随机实验室研究。
大学附属实验室。
成年雌性大鼠。
TIP 肽、突变型 TIP 肽、N,N'-二乙酰壳二糖/TIP 肽、阿米洛利/TIP 肽被气管内滴注到左肺,在进行同种异体移植前即刻给药。另外一组大鼠在移植前 1.5 分钟静脉内给予 TIP 肽。还进行了使用分离的大鼠 II 型肺泡上皮细胞单层和绵羊肺内皮细胞的研究。
TIP 肽而非无活性的突变型 TIP 肽预处理可显著改善移植肺的氧合作用,在移植后 24 小时氧合作用明显改善。这种治疗方法导致灌洗液中的中性粒细胞含量显著减少。上皮钠通道阻滞剂阿米洛利抑制了 TIP 肽对缺氧再复氧时肺动脉内皮细胞中活性氧物质生成的作用,也降低了体内移植大鼠肺组织中的活性氧物质含量。使用原代大鼠 II 型肺泡上皮细胞单层进行的 Ussing 室实验表明,该肽的主要作用部位在这些细胞的顶端侧。
这些数据表明,TIP 肽通过减少中性粒细胞含量和活性氧物质生成,显著改善了大鼠肺移植后的肺功能。这些研究提示 TIP 肽可能是一种针对肺移植相关缺血再灌注损伤的潜在治疗药物。